The Female Reproductive System & Ovarian Cycle
Every month, a woman's body builds a hormone-lined nursery. It releases a single egg capable of becoming a person. Then, if that egg goes unfertilized, the body dismantles the nursery and starts over. This is not a passive countdown. It is a tightly wired feedback circuit linking the brain, the pituitary gland, and the ovary. In this circuit, the same hormone (estrogen) can either suppress or trigger the surge that causes ovulation. This depends on its concentration and duration. Understanding how a single molecule can flip from a "stop" signal to a "go" signal is one of the most elegant lessons in endocrinology. The ovarian cycle matters far beyond reproduction. It is the reference system for understanding Endocrine signaling basics in action. Negative feedback, positive feedback, pulsatile hormone release, and receptor-mediated tissue remodeling all appear in one interlocking system. Its disruption underlies some of the most common conditions in medicine. These include polycystic ovary syndrome, infertility, dysfunctional uterine bleeding, and the rationale behind hormonal contraception and assisted reproduction. Comparing it with the The Male Reproductive System also reveals a deep asymmetry. Men produce gametes continuously from puberty onward. Women, however, are born with a fixed, dwindling supply of egg-containing follicles. This supply is depleted, not renewed. The big picture is this: two parallel cycles run in synchrony. The ovarian cycle governs follicle growth, egg release, and corpus luteum formation in the ovary. The uterine (menstrual) cycle governs the buildup and shedding of the uterine lining (endometrium). This is driven entirely by the hormones the ovary produces. Both cycles average 28 days. Both are controlled by a single hypothalamic-pituitary-ovarian axis. Its oscillations were mapped out through decades of hormone-assay experiments in the mid-20th century. This article walks through the mechanism of that axis step by step. It moves from GnRH pulses to the estrogen-driven LH surge to luteal regression. It then examines the classic endocrine experiments that established the causal logic of the cycle. Finally, it applies the concepts to worked clinical and quantitative examples.
- The ovarian cycle has two phases — follicular and luteal — separated by ovulation, roughly at day 14 of a 28-day cycle.
- FSH recruits a cohort of follicles; one becomes dominant and secretes rising estrogen, which suppresses FSH via negative feedback.
- High, sustained estrogen from the dominant follicle switches to a positive feedback signal, triggering the LH surge that causes ovulation.
- The corpus luteum secretes progesterone (plus estrogen) to sustain a receptive endometrium; without pregnancy, it regresses, hormones fall, and menstruation follows.
- The uterine cycle (menstrual, proliferative, secretory phases) is entirely driven by ovarian hormone output, not an independent clock.
- Hormonal contraceptives work by exploiting negative feedback to prevent the LH surge, blocking ovulation altogether.
Estrogen is a dual-purpose signal — low sustained levels suppress the pituitary, but a high sustained peak flips the same axis into positive feedback and triggers ovulation.
The core idea
The ovarian cycle is the approximately monthly sequence of events in the ovary that matures an oocyte and prepares it for release, driven by pulsatile gonadotropin-releasing hormone (GnRH) from the hypothalamus acting on the anterior pituitary. The pituitary responds with two gonadotropins — follicle-stimulating hormone (FSH) and luteinizing hormone (LH) — which act on the ovary to drive follicular growth, steroidogenesis, and ovulation. The cycle is conventionally divided into a follicular phase (follicle growth, dominated by rising estrogen), ovulation (release of the secondary oocyte), and a luteal phase (corpus luteum activity, dominated by progesterone). Running in parallel and entirely dependent on it is the uterine cycle, the cyclical remodeling of the endometrium (uterine lining) so that it can accept a fertilized egg. Its three phases — menstrual, proliferative, and secretory — are named for what is happening to the endometrium, and each corresponds to a specific hormonal phase of the ovarian cycle: menstruation coincides with the start of the follicular phase, the proliferative phase tracks rising estrogen, and the secretory phase tracks progesterone dominance during the luteal phase. Because the endometrium has no autonomous cycle of its own — remove the ovaries and menstruation stops — the uterine cycle is best understood as a downstream readout of ovarian hormone secretion. The key regulatory principle is feedback valence switching. Estrogen exerts negative feedback on GnRH/FSH/LH secretion at low-to-moderate, fluctuating concentrations (as during most of the follicular phase), but exerts positive feedback when its concentration is high and sustained for roughly 36–50 hours (as the dominant follicle matures). This single switch converts a self-limiting hormonal loop into a self-amplifying trigger — the LH surge — that is both necessary and sufficient to cause ovulation. No other steroid feedback loop in mammalian physiology behaves quite this way, which is why the ovarian cycle is often used to teach the general concept of context-dependent feedback polarity.
Mechanism
Step 1 — GnRH pulsatility sets the pace. Neurons in the hypothalamic arcuate nucleus release GnRH in discrete pulses, roughly every 60–120 minutes in the follicular phase, into the hypophyseal portal blood supplying the anterior pituitary. Pulse frequency and amplitude change across the cycle: faster, lower-amplitude pulses favor LH synthesis; slower, higher-amplitude pulses favor FSH. Continuous (non-pulsatile) GnRH, by contrast, paradoxically shuts the axis down by desensitizing pituitary receptors — the basis of GnRH-agonist drugs used clinically to suppress the reproductive axis.
Step 2 — FSH recruits a cohort of follicles. At the start of each cycle, a small rise in FSH rescues a cohort of 10–20 antral follicles from atresia (programmed degeneration). Each follicle consists of an oocyte surrounded by granulosa cells and, further out, thecal cells. This step draws on the enormous, non-renewable pool established before birth: a female fetus has roughly 6–7 million oocytes at 20 weeks gestation, already reduced to about 1–2 million at birth and roughly 300,000–400,000 by puberty — of which only about 400–500 will ever ovulate across a reproductive lifespan.
Step 3 — The two-cell, two-gonadotropin mechanism makes estrogen. Thecal cells, driven by LH, convert cholesterol to androgens (androstenedione). Granulosa cells, driven by FSH, express aromatase, which converts these androgens into estradiol. This division of labor means estrogen production strictly requires both LH-driven thecal androgen supply and FSH-driven granulosa aromatization — a mechanism confirmed by experiments showing that thecal and granulosa cells cultured separately cannot make estrogen efficiently, but co-cultures (or addition of thecal androgen to granulosa cultures) restore full estradiol output.
Step 4 — Dominance selection. By around day 5–7, one follicle (the dominant follicle) has acquired the most FSH receptors and the richest blood supply, allowing it to keep growing even as its own estrogen and inhibin output feed back to suppress pituitary FSH secretion. This falling FSH starves the remaining, less-developed follicles, which undergo atresia — a classic example of one structure winning a race by choking off the resource that all competitors need.
Step 5 — Rising estrogen flips to positive feedback. As the dominant follicle enlarges, its estradiol output climbs steeply, typically exceeding roughly 200 pg/mL and sustained above that threshold for at least 36–50 hours. This sustained high level switches hypothalamic and pituitary sensitivity: instead of suppressing GnRH/LH, high estrogen now stimulates a massive LH surge (and a smaller FSH surge), peaking about 24–36 hours before ovulation.
Step 6 — Ovulation. The LH surge triggers resumption of meiosis I in the oocyte (arrested since fetal life), luteinization of granulosa cells (they begin secreting progesterone), and local release of prostaglandins and proteolytic enzymes that digest the follicular wall and ovarian surface epithelium. The mature (Graafian) follicle ruptures, releasing a secondary oocyte arrested in metaphase II, surrounded by the cumulus oophorus, into the peritoneal cavity to be swept up by the fimbriae of the fallopian tube.
Step 7 — Luteal phase. The ruptured follicle collapses and transforms into the corpus luteum, a transient endocrine structure that secretes large amounts of progesterone plus moderate estrogen, sustained by low-level LH pulses. Progesterone raises basal body temperature by roughly 0.3–0.5 °C — the physiological basis of temperature-based ovulation tracking — and matures the endometrium into a secretory, glycogen-rich, highly vascular tissue ready for implantation.
Step 8 — Regression or rescue. If fertilization does not occur, the corpus luteum has an intrinsic lifespan of about 14 days and then regresses (becoming the corpus albicans), causing progesterone and estrogen to collapse. This hormonal withdrawal deprives the endometrium of hormonal support, triggering vasoconstriction of spiral arterioles, tissue ischemia, and shedding — menstruation — which also releases the pituitary from negative feedback, letting FSH rise again to start the next cycle. If fertilization occurs, the developing embryo's trophoblast secretes human chorionic gonadotropin (hCG), an LH-mimic that rescues the corpus luteum and maintains progesterone secretion, foreshadowing the hormonal basis of early Pregnancy Physiology.
The evidence
Establishing that the pituitary controls the ovary, not the reverse. In the 1920s and 1930s, researchers including Philip Smith and Herbert Evans showed that hypophysectomy (surgical removal of the pituitary) in rats caused ovarian atrophy, while injection of crude anterior pituitary extracts into immature rodents induced precocious follicular growth and ovulation. This established that the pituitary, not the ovary itself, was the proximate driver of ovarian cyclicity — setting up the search for the specific gonadotropic hormones (later purified as FSH and LH).
Establishing pulsatile GnRH as necessary and sufficient. The most decisive experiment came from Ernst Knobil's group in the 1970s–80s, working with rhesus monkeys whose arcuate nucleus (the hypothalamic GnRH pulse generator) had been destroyed by radiofrequency lesions. These animals became permanently hypogonadotropic — LH and FSH fell to near zero and cycling stopped completely, despite an intact pituitary. When GnRH was then infused continuously (mimicking a constant, non-pulsatile signal), gonadotropin secretion remained suppressed. But when the identical total dose of GnRH was delivered in pulses — one pulse per hour — normal LH and FSH secretion resumed, and the monkeys began ovulating again. This directly proved that pulse frequency, not just hormone presence, is the coding signal that the pituitary reads, and that continuous GnRH exposure paradoxically desensitizes the axis. It remains the single cleanest causal demonstration in reproductive endocrinology and is the physiological basis for GnRH-agonist drugs (used to suppress puberty or treat endometriosis and prostate cancer) as well as pulsatile GnRH pumps used to induce fertility in hypothalamic amenorrhea.
Establishing the estrogen switch from negative to positive feedback. Classic experiments in ovariectomized rhesus monkeys and rats (extending work by Geoffrey Harris, Roger Short, and others from the 1950s–70s) showed that low, constant estradiol replacement suppressed LH (negative feedback, mimicking the follicular phase baseline), while a single injection of a high dose of estradiol, sustained for roughly 36–48 hours, was sufficient by itself — with no other ovarian input — to trigger an LH surge indistinguishable from a natural preovulatory surge. This experiment isolated estrogen concentration and duration as the sufficient trigger for the surge, independent of any other follicular signal, cleanly establishing the positive-feedback switch as an intrinsic property of the estrogen–pituitary axis itself.
Establishing corpus luteum dependence and hCG rescue. Removal of the corpus luteum (luteectomy) in early pregnancy in various mammals, and in early human pregnancy case studies, causes miscarriage unless performed after roughly 7–9 weeks (when the placenta itself takes over progesterone production) — demonstrating that the corpus luteum, not the uterus, is what maintains early pregnancy, and confirming why hCG (detected by pregnancy tests) exists specifically to rescue it from its otherwise fixed 14-day lifespan.
Worked examples
Example 1 — Reading a basal body temperature and hormone chart to date ovulation and diagnose a luteal phase defect. A patient reports a 35-day cycle. Basal body temperature (BBT) stays at 36.4 °C from day 1 through day 21, then rises to 36.9 °C on day 22 and stays elevated through day 35, when menstruation begins. Reasoning: the temperature rise is caused by progesterone from the corpus luteum, so the shift marks the start of the luteal phase, meaning ovulation occurred around day 21 (one day before the rise, since progesterone takes about 24 hours to raise BBT).
That is exactly the expected fixed luteal phase length, so the corpus luteum lifespan is normal. The follicular phase, by contrast, lasted 21 days — much longer than the typical 10–14 days — meaning the extra cycle length comes entirely from delayed follicular development (e.g., slow FSH rise or a sluggish dominant follicle), not a luteal defect. This distinction matters clinically: a short luteal phase (< 10 days) suggests inadequate progesterone support for implantation, whereas a long follicular phase suggests anovulatory tendency (as seen in PCOS) but a still-functional corpus luteum once ovulation eventually occurs.
Example 2 — Predicting the effect of a combined oral contraceptive using feedback logic. A combined pill delivers a constant low dose of synthetic estrogen and progestin daily, rather than the naturally fluctuating, steeply rising estrogen of the late follicular phase. Reasoning: recall that the LH surge specifically requires estrogen to reach a high concentration and remain there for 36–50 hours — a spike, not a plateau. A constant low dose instead mimics early-to-mid follicular phase estrogen levels indefinitely. Consequence chain: 1. Constant low estrogen + progestin → sustained negative feedback on hypothalamus and pituitary. 2. GnRH pulse frequency and FSH/LH output stay low and flat — no cohort of follicles is ever recruited to dominance. 3. No dominant follicle → no steep estrogen rise → the positive-feedback threshold is never reached. 4. No LH surge → no ovulation. 5. Progestin additionally thickens cervical mucus (blocking sperm transit) and thins the endometrium (reducing implantation receptivity), providing backup contraceptive mechanisms even in a breakthrough ovulation. This shows why missing pills specifically during the early pill-free interval (when FSH would naturally start rising) is the highest-risk lapse for ovulation and pregnancy — it gives the axis its best chance to escape suppression and recruit a dominant follicle before the next dose restores negative feedback.
Common misconceptions & traps
| Misconception | Reality |
|---|---|
| "Ovulation always happens on day 14." | Day 14 assumes a 28-day cycle with a fixed 14-day luteal phase; the follicular phase length is what varies between people and cycles, so ovulation timing shifts accordingly. |
| "Estrogen is 'the female hormone' that always suppresses the pituitary." | Estrogen's feedback sign depends on concentration and duration — sustained high levels stimulate the LH surge (positive feedback), the opposite of its usual role. |
| "The uterus has its own independent monthly clock." | The endometrium has no autonomous rhythm; it merely responds to circulating estrogen and progesterone. Remove the ovaries and the uterine cycle stops entirely. |
| "Women continuously make new eggs, like men make new sperm." | Oocyte number is fixed before birth (peaking near 6–7 million at mid-gestation) and only declines afterward through atresia and ovulation — there is no adult oogenesis. |
| "The corpus luteum is a permanent gland." | It is a transient structure with an intrinsic ~14-day lifespan that regresses automatically unless rescued by hCG from an implanting embryo. |
| "Menstruation is the cycle's starting event caused by 'low hormones building up.'" | Menstruation is the consequence of corpus luteum regression and hormone withdrawal — a downstream effect, not an independent trigger. |
The scientist behind it
Origins · 1 minErnst Knobil and how this was discovered
Knobil built one of the most rigorous experimental systems in endocrinology: rhesus monkeys with radiofrequency-lesioned arcuate nuclei, rendered permanently hypogonadotropic, into which he could deliver GnRH via programmable infusion pumps with exact control over pulse frequency, amplitude, and duration. This let him isolate pulsatility itself — rather than hormone presence — as the coding variable the pituitary reads, a level of causal precision rarely achievable in intact endocrine physiology. His work reframed the hypothalamic-pituitary-gonadal axis as a frequency-modulated signaling system, directly inspiring pulsatile GnRH pump therapy for infertility and the rationale behind continuous GnRH-agonist suppression used in modern reproductive medicine and oncology.
Where this matters today
Assisted reproduction (IVF). Controlled ovarian hyperstimulation uses exogenous FSH to override the natural dominance mechanism, rescuing multiple follicles simultaneously; GnRH antagonists or agonists are given concurrently to prevent a premature natural LH surge, and a precisely timed hCG (or GnRH-agonist) "trigger shot" mimics the natural surge to finalize oocyte maturation before retrieval.
Hormonal contraception. Combined pills, patches, rings, and hormonal IUDs all exploit the negative-feedback arm of the axis to suppress FSH/LH and prevent dominant-follicle selection, while progestin-only methods primarily block ovulation and thicken cervical mucus.
Infertility diagnosis. Measuring day-3 FSH/estradiol, mid-luteal progesterone, and anti-Müllerian hormone (a marker of remaining follicle reserve secreted by small antral follicles) lets clinicians estimate ovarian reserve and pinpoint whether infertility stems from anovulation, luteal insufficiency, or diminished egg supply.
PCOS and anovulatory disorders. Polycystic ovary syndrome involves disrupted LH pulsatility (often elevated LH relative to FSH), excess thecal androgen production, and failure of any single follicle to achieve dominance — directly traceable to breakdowns at specific steps of the mechanism described above, and treatable by drugs (like clomiphene or letrozole) that manipulate the same feedback loop to force an FSH rise.
Menopause and hormone therapy. As the finite oocyte pool nears depletion, remaining follicles become less responsive, estrogen and inhibin production fall, and FSH rises sharply (a clinically used marker of menopausal transition) because the negative feedback that once restrained it is lost — informing decisions about hormone replacement therapy and its cardiovascular and bone-density tradeoffs.
Conservation and livestock breeding. Estrus synchronization protocols in cattle and endangered-species breeding programs apply the same GnRH/progestin manipulation used in human contraception and IVF, timing ovulation across whole herds or captive populations for efficient artificial insemination.
Ask the tutor: How would a single missed birth-control pill during the first week of a pack differently affect ovulation risk compared to a missed pill in the third week?
Why does the ovarian cycle length vary between individuals more than the luteal phase does?
The luteal phase is tightly constrained by the corpus luteum's intrinsic, hormonally-programmed lifespan of about 14 days, which does not change much between cycles or people. The follicular phase, however, depends on how quickly a cohort of follicles responds to FSH and how fast one achieves dominance — a process sensitive to stress, body weight, illness, and age. Because total cycle length is essentially follicular phase length plus a fixed 14-day luteal phase, most of the variability in cycle length (the classic 21–35 day range) comes from the follicular phase, not the luteal phase. Clinically, a persistently short luteal phase (under about 10 days) is considered abnormal and associated with implantation failure, while follicular phase variability alone is usually not.
How does menopause fit into this feedback framework?
Menopause reflects exhaustion of the finite ovarian follicle reserve established before birth. As fewer follicles remain and respond poorly to FSH, estrogen and inhibin output falls. Because these hormones normally suppress FSH via negative feedback, their decline removes that brake, and pituitary FSH rises sharply — often to several times premenopausal levels. This elevated FSH, measured clinically, is a hallmark marker of the menopausal transition. Ovulation becomes irregular and eventually stops entirely once no follicles remain capable of responding. Estrogen withdrawal also explains many menopausal symptoms (hot flashes, bone density loss), since estrogen has widespread non-reproductive tissue effects beyond the ovarian cycle itself.
What exactly triggers the physical rupture of the follicle at ovulation?
The LH surge does more than mature the oocyte — it also induces local synthesis of prostaglandins and proteolytic enzymes (including plasminogen activator and collagenases) within the follicular wall. These enzymes digest structural collagen and the ovarian surface epithelium at a defined weak point called the stigma, while prostaglandin-mediated smooth muscle contraction and increased follicular fluid pressure help expel the oocyte-cumulus complex. This is a controlled, enzyme-driven rupture rather than simple pressure buildup, which is why nonsteroidal anti-inflammatory drugs (which block prostaglandin synthesis) can, in some cases, delay or impair ovulation.
Why is the fixed, non-renewable oocyte pool biologically significant?
Unlike sperm production, which continues throughout adult male life via ongoing spermatogonial stem cell division, oocyte number is set during fetal development and only decreases afterward — through both ovulation and a much larger background process of atresia that eliminates the vast majority of follicles without ever ovulating. This finite reserve is the biological basis of age-related fertility decline and rising rates of chromosomal abnormalities in offspring with maternal age, since surviving oocytes have been arrested in meiosis I for decades, accumulating higher risk of nondisjunction. It also explains why ovarian reserve markers such as anti-Müllerian hormone are used clinically to estimate a woman's remaining reproductive window.
How do hormonal contraceptives differ in mechanism from natural infertility during breastfeeding (lactational amenorrhea)?
Both suppress ovulation through the same underlying feedback logic but via different signals. Combined oral contraceptives supply constant exogenous estrogen and progestin that flatten the natural estrogen rise, preventing the sustained high-estrogen trigger needed for an LH surge. Lactational amenorrhea instead works through frequent suckling-induced prolactin release, which suppresses GnRH pulse frequency directly at the hypothalamus, keeping FSH and LH too low and infrequent to drive follicular dominance. Both converge on the same outcome — no LH surge, no ovulation — but contraceptives act by hormone-level mimicry downstream, while lactation acts by altering the GnRH pulse generator upstream.
Why does removing the corpus luteum only cause miscarriage before about 7–9 weeks of pregnancy?
Early pregnancy is entirely dependent on corpus luteum progesterone to maintain the endometrium, because the placenta has not yet matured enough to produce sufficient steroid hormone on its own. Embryonic hCG rescues the corpus luteum from its normal 14-day regression, keeping progesterone secretion high through roughly the first two to three months. Around 7–9 weeks, the developing placenta itself becomes capable of independent progesterone synthesis in adequate amounts — a transition called the "luteal-placental shift." After that point, surgically removing the corpus luteum or ovary no longer threatens the pregnancy, because the placenta has taken over hormonal support entirely.
Is the 28-day cycle the biological "normal," and does variation indicate a problem?
No — 28 days is a population average used for teaching, not a universal biological requirement. Clinically normal cycles range from about 21 to 35 days, with most of that variability arising from the follicular phase rather than the fixed ~14-day luteal phase. Cycle length can shift with stress, exercise, body composition, illness, and age without indicating pathology, though persistent cycles far outside that range, absent periods, or a very short luteal phase can indicate anovulation, thyroid dysfunction, or other endocrine disorders worth clinical evaluation.